ICU Medical, Inc. is voluntarily recalling one lot each of POTASSIUM CHLORIDE Inj. bags with overwrap labels 10 mEq, packaged ...

Nexus Pharmaceuticals, LLC announces the U.S Food and Drug Administration (FDA) approval of Tacrolimus Injection 5 mg/mL. Nexus’ Tacrolimus Injection is the first and only vial that will be available.

Compared with a placebo injection, platelet-rich plasma injections yielded similar outcomes at 1 year for patients with ...

The FDA has expanded the labeling for Izervay (avacincaptad pegol) to include longer-term administration for geographic ...

Provepharm Inc. is conducting a voluntary nationwide recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL (Pharmacy ...

The inertial fusion energy project is funded by the U.S. Department of Energy (DOE) and includes the Lawrence Livermore ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Dr. Kaja Falkenhain, postdoctoral researcher at Pennington Biomedical Research Center, has been awarded a postdoctoral ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...